New Diagnostics to Combat MRSA 'Superbug'

Clinician's Roundtable
17/02/2009 14 min

Listen "New Diagnostics to Combat MRSA 'Superbug' "

Descargar episodio Ver en sitio original

Episode Synopsis



Host: Bruce Japsen

Guest: Jian Han, MD



The 'superbug' methicillin-resistant staphylococcus aureus, or MRSA, is a top concern for hospitals and doctors nationwide. So what are we doing to combat this? Dr. Gian Han, director of Diatherix Laboratories, tells host Bruce Japsen about molecular diagnostic technologies being developed for doctors to detect MRSA and prevent infection in patients.

More episodes of the podcast Clinician's Roundtable

Managing Bleeding Risk in Fracture Patients on Anticoagulation 14/01/2026
The Hidden Respiratory Burden of Obesity: Understanding the Clinical Consequences 02/01/2026
Understanding the Growing Impacts of Obesity on Patient Outcomes and Care Delivery 02/01/2026
MASLD Explained: A Modern Framework for a Multisystem Condition 02/01/2026
From Gut Microbe to Metabolic Modulator: The Potential Role of R. hominis in Obesity 31/12/2025
Reconnecting With Patients: A Human-Centered Approach to Everyday Practice 09/12/2025
Timely Surgery for Hip Fractures: Addressing Anticoagulant Challenges 05/12/2025
Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy 19/11/2025
Improving Perioperative Medication Safety with Ready-to-Administer Products 18/11/2025
Uncovering the Disease Burden of Untreated Pediatric TK2 Deficiency 18/11/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA